Clinical Trials for Platinum-Refractory Fallopian Tube Carcinoma

Find clinical trials for platinum-refractory fallopian tube carcinoma. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a and 2) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.

NCT ID: NCT05271318

This clinical trial, called TILT-123, is investigating a new treatment for women with certain types of ovarian cancer that have not responded to standard chemotherapy (known as platinum-resistant o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Helsinki, , Finland +3 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions